Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.
Paleobiology Professor Kenshu Shimada is leading a study alongside 28 experts. A new scientific study offers significant ...
The Belgian government and French utility Engie have closed the agreement covering the extension of the operation of the ...